Minimally Invasive Glaucoma Surgery (MIGS) Devices Market By Device Type (Stents {Intraocular stents, Ab-interno stents}, Implants {Trabecular implants, Suprachoroidal implants}, Laser Systems {Selective laser trabeculoplasty (SLT), Other laser devices}, Goniotomy Devices), By Target (Trabecular Meshwork Bypass, Suprachoroidal Space, Subconjunctival Space, Schlemm’s Canal, Others), By Glaucoma Type (Primary Open-Angle Glaucoma (POAG), Angle-Closure Glaucoma, Secondary Glaucoma, Normal Tension Glaucoma, Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing prevalence of glaucoma boosts demand for effective treatments.

3.2.2. Patients prefer minimally invasive procedures due to quicker recovery.

3.2.3. Technological advancements enhance the safety and effectiveness of MIGS devices.

3.3. Key industry pitfalls & challenges

3.3.1. Inadequate reimbursement policies restrict healthcare provider adoption rates.

3.3.2. High procedural costs limit patient access, especially in developing areas.

3.3.3. Limited awareness in emerging markets hinders market growth potential.

3.4. Market Opportunities

3.4.1. Development of new technologies can enhance MIGS efficacy and safety.

3.4.2. Telemedicine integration facilitates early diagnosis and treatment planning.

3.4.3. Personalized medicine approaches can improve patient outcomes and satisfaction.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Device Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Device Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Stents

4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.2.2. Intraocular stents

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.2.3. Ab-interno stents

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3. Implants

4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3.2. Trabecular implants

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3.3. Suprachoroidal implants

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4. Laser Systems

4.4.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4.2. Selective laser trabeculoplasty (SLT)

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4.3. Other laser devices

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.5. Goniotomy Devices

4.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Target Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Target, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Trabecular Meshwork Bypass

5.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3. Suprachoroidal Space

5.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.4. Subconjunctival Space

5.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5.5. Schlemm’s Canal

5.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Million)

6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Glaucoma Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Glaucoma Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Primary Open-Angle Glaucoma (POAG)

6.2.1. Market Size and Forecast, 2025-2035 (USD Million)

6.3. Angle-Closure Glaucoma

6.3.1. Market Size and Forecast, 2025-2035 (USD Million)

6.4. Secondary Glaucoma

6.4.1. Market Size and Forecast, 2025-2035 (USD Million)

6.5. Normal Tension Glaucoma

6.5.1. Market Size and Forecast, 2025-2035 (USD Million)

6.6. Others

6.6.1. Market Size and Forecast, 2025-2035 (USD Million)

7. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, End-User Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-User, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals

7.2.1. Market Size and Forecast, 2025-2035 (USD Million)

7.3. Ambulatory Surgical Centers (ASCs)

7.3.1. Market Size and Forecast, 2025-2035 (USD Million)

7.4. Specialty Clinics

7.4.1. Market Size and Forecast, 2025-2035 (USD Million)

8. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Million)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Million)

8.2.2. North America Market Revenue, By Device Type, 2025-2035

8.2.3. North America Market Revenue, By Target, 2025-2035

8.2.4. North America Market Revenue, By Glaucoma Type, 2025-2035

8.2.5. North America Market Revenue, By End-User, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Device Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Target, 2025-2035

8.2.6.3. U.S. Market Revenue, By Glaucoma Type, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-User, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Device Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Target, 2025-2035

8.2.7.3. Canada Market Revenue, By Glaucoma Type, 2025-2035

8.2.7.4. Canada Market Revenue, By End-User, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Million)

8.3.2. Europe Market Revenue, By Device Type, 2025-2035

8.3.3. Europe Market Revenue, By Target, 2025-2035

8.3.4. Europe Market Revenue, By Glaucoma Type, 2025-2035

8.3.5. Europe Market Revenue, By End-User, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Device Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Target, 2025-2035

8.3.6.3. Germany Market Revenue, By Glaucoma Type, 2025-2035

8.3.6.4. Germany Market Revenue, By End-User, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Device Type, 2025-2035

8.3.7.2. France Market Revenue, By Target, 2025-2035

8.3.7.3. France Market Revenue, By Glaucoma Type, 2025-2035

8.3.7.4. France Market Revenue, By End-User, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Device Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Target, 2025-2035

8.3.8.3. U.K. Market Revenue, By Glaucoma Type, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-User, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Device Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Target, 2025-2035

8.3.9.3. Italy Market Revenue, By Glaucoma Type, 2025-2035

8.3.9.4. Italy Market Revenue, By End-User, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Device Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Target, 2025-2035

8.3.10.3. Spain Market Revenue, By Glaucoma Type, 2025-2035

8.3.10.4. Spain Market Revenue, By End-User, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Device Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Target, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Glaucoma Type, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-User, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Million)

8.4.2. Asia Pacific Market Revenue, By Device Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Target, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Glaucoma Type, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-User, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Device Type, 2025-2035

8.4.6.2. China Market Revenue, By Target, 2025-2035

8.4.6.3. China Market Revenue, By Glaucoma Type, 2025-2035

8.4.6.4. China Market Revenue, By End-User, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Device Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Target, 2025-2035

8.4.7.3. Japan Market Revenue, By Glaucoma Type, 2025-2035

8.4.7.4. Japan Market Revenue, By End-User, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Device Type, 2025-2035

8.4.8.2. India Market Revenue, By Target, 2025-2035

8.4.8.3. India Market Revenue, By Glaucoma Type, 2025-2035

8.4.8.4. India Market Revenue, By End-User, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Device Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Target, 2025-2035

8.4.9.3. Australia Market Revenue, By Glaucoma Type, 2025-2035

8.4.9.4. Australia Market Revenue, By End-User, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Device Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Target, 2025-2035

8.4.10.3. South Korea Market Revenue, By Glaucoma Type, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-User, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Device Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Target, 2025-2035

8.4.11.3. Singapore Market Revenue, By Glaucoma Type, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-User, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Device Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Target, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Glaucoma Type, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-User, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Million)

8.5.2. Latin America Market Revenue, By Device Type, 2025-2035

8.5.3. Latin America Market Revenue, By Target, 2025-2035

8.5.4. Latin America Market Revenue, By Glaucoma Type, 2025-2035

8.5.5. Latin America Market Revenue, By End-User, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Device Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Target, 2025-2035

8.5.6.3. Brazil Market Revenue, By Glaucoma Type, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-User, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Device Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Target, 2025-2035

8.5.7.3. Argentina Market Revenue, By Glaucoma Type, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-User, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Device Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Target, 2025-2035

8.5.8.3. Mexico Market Revenue, By Glaucoma Type, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-User, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Device Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Target, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Glaucoma Type, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-User, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Million)

8.6.2. MEA Market Revenue, By Device Type, 2025-2035

8.6.3. MEA Market Revenue, By Target, 2025-2035

8.6.4. MEA Market Revenue, By Glaucoma Type, 2025-2035

8.6.5. MEA Market Revenue, By End-User, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Device Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Target, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Glaucoma Type, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-User, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Device Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Target, 2025-2035

8.6.7.3. South Africa Market Revenue, By Glaucoma Type, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-User, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Device Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Target, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Glaucoma Type, 2025-2035

8.6.8.4. Rest of Middle-East & Africa Market Revenue, By End-User, 2025-2035

9. Company Profile

9.1. Alcon

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. AbbVie (Allergan)

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Glaukos Corporation

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Santen Pharmaceutical

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Bausch + Lomb

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Microsurgical Technology (MST)

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Sight Sciences

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Aerie Pharmaceuticals

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Lumenis

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Eyenovia

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Oraya Therapeutics

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Katalyst Surgical

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. InspireMD

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Karl Storz

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. SurgiCare

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis